Xpert MTB/RIF as a measure of sputum bacillary burden: Variation by HIV status and immunosuppression

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 11, 2014, Pages 1426-1434

  Hanrahan, Colleen F ^a   Theron, Grant ^b   Bassett, Jean ^c   Dheda, Keertan ^b   Scott, Lesley ^d   Stevens, Wendy ^d   Sanne, Ian ^e,f   Van Rie, Annelies ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Witkoppen Health and Welfare Centre   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^f RIGHT TO CARE   (South Africa)

Author keywords

Diagnostics; South Africa; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIAL LOAD; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CULTURE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM CULTURE; SPUTUM SMEAR; TIME TO CULTURE POSITIVITY; XPERT MTB RIF;

ADULT; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84901811250     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201312-2140OC     Document Type: Article

References (31)

1. Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954;69:724-732.
2. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, Small PM. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353:444-449. (Pubitemid 29067335)
3. Jindani A, Doré CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003;167:1348-1354. (Pubitemid 36609718)
4. Pheiffer C, Carroll NM, Beyers N, Donald P, Duncan K, Uys P, van Helden P. Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting. Int J Tuberc Lung Dis 2008;12:792-798. (Pubitemid 351976711)
5. Perrin FM, Woodward N, Phillips PP, McHugh TD, Nunn AJ, Lipman MC, Gillespie SH. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010;14:1596-1602.
6. Diacon AH, Maritz JS, Venter A, van Helden PD, Andries K, McNeeley DF, Donald PR. Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. Eur J Clin Microbiol Infect Dis 2010;29:1561-1565.
7. Fennelly KP, Jones-López EC, Ayakaka I, Kim S, Menyha H, Kirenga B, Muchwa C, Joloba M, Dryden-Peterson S, Reilly N, et al. Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2012;186:450-457.
8. World Health Organization. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance. Xpert MTB/RIF system. Geneva, Switzerland: World Health Organization; 2011.
9. Blakemore R, Nabeta P, Davidow AL, Vadwai V, Tahirli R, Munsamy V, Nicol M, Jones M, Persing DH, Hillemann D, et al. A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med 2011;184:1076-1084.
10. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, nearpatient technology. J Clin Microbiol 2010;48:229-237.
11. van Zyl-Smit RN, Binder A, Meldau R, Mishra H, Semple PL, Theron G, Peter J, Whitelaw A, Sharma SK, Warren R, et al. Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS ONE 2011;6:e28815.
12. Theron G, Pinto L, Peter J, Mishra HK, Mishra HK, van Zyl-Smit R, Sharma SK, Dheda K. The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients. Clin Infect Dis 2012;54:384-388.
13. Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, Ntinginya EN, O'Grady J, Huggett J, Dheda K, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay: a clinical validation study. PLoS ONE 2011;6:e20458.
14. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. Signifi cant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis 2010;14:1295-1302.
15. Elliott AM, Namaambo K, Allen BW, Luo N, Hayes RJ, Pobee JO, McAdam KP. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis 1993;74:191-194. (Pubitemid 23188682)
16. Joloba ML, Johnson JL, Namale A, Morrissey A, Assegghai AE, Mugerwa RD, Ellner JJ, Eisenach KD. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis 2000;4:528-536. (Pubitemid 30409169)
17. Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Britton S, Feleke Y, Källenius G, Lindquist L. Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics. Scand J Infect Dis 2002;34:331-337. (Pubitemid 34746250)
18. Chaidir L, Parwati I, Annisa J, Muhsinin S, Meilana I, Alisjahbana B, van Crevel R. Implementation of LED fluorescence microscopy for diagnosis of pulmonary and HIV-associated tuberculosis in a hospital setting in Indonesia. PLoS ONE 2013;8:e61727.
19. Harries AD, Maher D, Nunn P. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World Health Organ 1998;76:651-662. (Pubitemid 29143879)
20. World Health Organization. WHO monitoring of Xpert MTB/RIF roll-out. 2013 [accessed 2013 Aug 1]. Available from: http://www.who.int/tb/laboratory/ mtbrifrollout/en/.
21. Hanrahan C, Selibas K, Cunningham B, Deery CB, Scott L, Stevens W, Sanne I, Van Rie A. Quantitative Xpert MTB/RIF and the role of HIV among a cohort of TB suspects: South Africa. Presented at the Conference on Retroviruses and Opportunistic Infections. March 3-6, 2013. Atlanta, GA.
22. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011;184:132-140.
23. Enarson DA, Rieder HL, Arnadottir TA. Management of tuberculosis: a guide for low income countries. Paris, France: IUATLD; 2000.
24. Haukoos JS, Lewis RJ. Advanced statistics: bootstrapping confidence intervals for statistics with "difficult" distributions. Acad Emerg Med 2005;12:360 -365.
25. Myers L, Sirois MJ. Differences between Spearman correlation coeffi cients. In: Kotz S, Read CB, Balakrishnan N, Vidakovic B, editors. Encyclopedia of statistical sciences. Hoboken, NJ: John Wiley and Sons; 2004. pp. 1-2.
26. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013;1:CD009593.
27. Aziz M. External quality assessment for AFB smear microscopy. Washington, DC: Association of Public Health Laboratories; 2002.
28. Kayigire XA, Friedrich SO, Venter A, Dawson R, Gillespie SH, Boeree MJ, Heinrich N, Hoelscher M, Diacon AH; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics. Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity. J Clin Microbiol 2013;51:1894-1898.
29. Escombe AR, Moore DA, Gilman RH, Pan W, Navincopa M, Ticona E, Martínez C, Caviedes L, Sheen P, Gonzalez A, et al. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med 2008;5:e188.
30. Hernández-Garduño E, Cook V, Kunimoto D, Elwood RK, Black WA, FitzGerald JM. Transmission of tuberculosis from smear negative patients: a molecular epidemiology study. Thorax 2004;59:286-290. (Pubitemid 38496744)
31. Tostmann A, Kik SV, Kalisvaart NA, Sebek MM, Verver S, Boeree MJ, van Soolingen D. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 2008;47:1135-1142.